Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

One Nucleus

- PMLiVE

Stories of sickness: applying illness narratives to health advertising

By Dr Stephanie Goley Introduction As advertisers, we know that health and pharmaceutical campaigns hold enormous influence over how the public perceives illness, wellness, and treatment. But too often, our...

11 London

- PMLiVE

Labour Party takes aim at pharma, calls attention to Orkambi row

Proposal to introduce compulsory licensing faces industry criticism

- PMLiVE

Boris Johnson is new PM – but opposition to his Brexit plans mount

Brexit rhetoric unrealistic, suggests biotech leader

- PMLiVE

Threat of no-deal damaging life sciences, says UK biotech leader

Calls for better-informed debate among Conservative candidates

- PMLiVE

No deal or revoke looming as fourth vote on Brexit nears

Voters set to protest via EU elections, no-deal remains possibility

- PMLiVE

Brexit clock ticking once again, UK heads for European elections

New deadline gives pharma more time, but no more clarity

- PMLiVE

Pharma industry swamped with no-deal Brexit info, says BIA

Deluge comes just as prime minister hints at delay

- PMLiVE

As government rushes through no-deal legislation, UK biotech repeats Brexit plea

UK market would be relegated in importance

- PMLiVE

Budget 2018: UK life sciences sector delivers its verdict

UK Chancellor Philip Hammond delivered a budget that was broadly pro-business but contained mixed news for the life sciences industry, according to two industry bodies.The headline news of an additional...

- PMLiVE

MHRA: No change for pre-Brexit products after UK exits the EU

And UK plans to follow EU rules for an implementation period after March 2019

- PMLiVE

BIA launches R&D communications best practice guide

Aims to support UK bioscience groups interacting with investors and the public

- PMLiVE

EU and UK pharma leaders appeal directly to Brexit negotiators

EFPIA, ABPI and BIA warn Michel Barnier and David Davies an unorderly withdrawal could hit medicine supplies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links